Uncategorized
VIDEO: Aerie announces Rocklatan launch
SAN DIEGO ― At the Ophthalmology Innovation Summit, Vicente J. Anido Jr., PhD, chairman and CEO of Aerie Pharmaceuticals, discusses the market launch of Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% in the U.S., as well as the company’s pipeline and progress in international markets.